Skip to content

Clinical trials

Choroidal Neovascularization trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Choroidal Neovascularization Clear all

203 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20002
20013
20022
20034
20047
200511
200617
200721
200815
20097
201016
20119
20129
20139
20145
20159
20165
20175
20185
20195
20207
20218
20224
20233
20242
20256
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed135
Terminated23
Unknown status20
Withdrawn9
Recruiting6
Active, not recruiting6
Not yet recruiting4

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals20
National Eye Institute (NEI)11
Notal Vision Ltd.7
Novartis7
Medical University of Vienna6
GlaxoSmithKline5
Johns Hopkins University5
Alcon Research4
Allergan4
Bayer4

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Choroidal Neovascularization203
Macular Degeneration132
Wet Macular Degeneration16
Diabetic Retinopathy11
Eye Diseases11
Geographic Atrophy11
Retinal Diseases11
Macular Edema9
Retinal Vein Occlusion9
Vision Disorders9

Trials

Showing 76 to 100 of 203. Each trial links to its page on Pharma Observatory.

103 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.